Fabrication, Characterization, and In Vivo Evaluation of Famotidine Loaded Solid Lipid Nanoparticles for Boosting Oral Bioavailability

Table 2

Formulations of FTD-SLNs.

Formulation	Stearic acid (g)	FTD (mg)	Tween-80 (ml)	PVP (g)	Stirring time (min)
FFSe-1	1.00	40	1.6	0.4	15
FFSe-2	1.00	50	1.6	0.4	15
FFSe-3	1.00	66.6	1.6	0.4	15
FFSe-4	1.00	100	1.6	0.4	15
FFSe-5	1.00	200	1.6	0.4	15

FTD: famotidine; PVP: polyvinyl pyrrolidone.